Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.

Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001104659-24-026155 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-21	2024-02-16	RYTM	Shulman Joseph	Chief Technical Off	A - Grant	$0.00	+33.8K	33.8K	+112,500%	$0
DM	2024-02-21	2024-02-16	RYTM	Shulman Joseph	Chief Technical Off	A - Grant	$0.00	+66.8K	16.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-16	A	A	33,750	$0.00	33,780	D	—	—	(F1) The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.
2	Derivative	Stock Option (Right to Buy)	2024-02-16	A	A	50,250	$0.00	50,250	D	$49.23 · — to 2034-02-15	50,250 Common Stock	(F4) The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
3	Derivative	Restricted Stock Units	2024-02-16	A	A	16,500	$0.00	16,500	D	— · — to —	16,500 Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.